Atazanavir 300 mg
Atazanavir 300 mg is a protease inhibitor indicated for use in boosted antiretroviral regimens, where it plays a key role in suppressing HIV replication when combined with a pharmacokinetic enhancer and other antiretroviral agents, in line with established treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily administered with an appropriate pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral medicines, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets